Cell Point (India) (NSE:CELLPOINT) EBIT: ₹74 Mil (TTM As of Mar. 2026)


NSE:CELLPOINT Cell Point (India) Ltd NSE:CELLPOINT
73 GF Score
Price ₹15.85
GF Value ₹34.71
Valuation Significantly Undervalued
! 7 Warning Signs
View Full Analysis

What is Cell Point (India) EBIT?

Cell Point (India) NSE:CELLPOINT 73 EBIT is ₹74 Mil as of Mar. 2026. GuruFocus rates NSE:CELLPOINT with a GF Score™ of 73/100 and a GF Value™ of ₹34.71 (Significantly Undervalued). The stock has 7 warning signs investors should review.

Cell Point (India)'s earnings before interest and taxes (EBIT) for the six months ended in Mar. 2026 was ₹42 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Mar. 2026 was ₹74 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Cell Point (India)'s annualized ROC % for the quarter that ended in Mar. 2026 was 0.00%. Cell Point (India)'s annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 7.40%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Cell Point (India)'s Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 7.35%.

Cell Point (India)  (NSE:CELLPOINT) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Cell Point (India)'s annualized ROC % for the quarter that ended in Mar. 2026 is calculated as:

ROC % (Q: Mar. 2026 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Sep. 2025 ) + Invested Capital (Q: Mar. 2026 ))/ count )
=77.844 * ( 1 - 100% )/( (1404.079 + 1497.091)/ 2 )
=0/1450.585
=0.00 %

where

Invested Capital(Q: Sep. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=1626.091 - 182.582 - ( 59.005 - max(0, 780.617 - 820.047+59.005))
=1404.079

Invested Capital(Q: Mar. 2026 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=1691.05 - 134.691 - ( 59.268 - max(0, 629.831 - 858.719+59.268))
=1497.091

Note: The Operating Income data used here is two times the semi-annual (Mar. 2026) data.

2. Joel Greenblatt's definition of Return on Capital:

Cell Point (India)'s annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 is calculated as:

ROC (Joel Greenblatt) %(Q: Mar. 2026 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Sep. 2025  Q: Mar. 2026
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=83.758/( ( (581.814 + max(546.039, 0)) + (603.252 + max(531.412, 0)) )/ 2 )
=83.758/( ( 1127.853 + 1134.664 )/ 2 )
=83.758/1131.2585
=7.40 %

where Working Capital is:

Working Capital(Q: Sep. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(9.373 + 702.747 + 39.582) - (182.582 + 0 + 23.081)
=546.039

Working Capital(Q: Mar. 2026 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(9.6 + 663.194 + 28.872) - (134.691 + 0 + 35.563)
=531.412

When net working capital is negative, 0 is used.

Note: The EBIT data used here is two times the semi-annual (Mar. 2026) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Cell Point (India)'s Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Mar. 2026 )
=74.128/1007.971
=7.35 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cell Point (India) EBIT Related Terms

Cell Point (India) EBIT Historical Data

* Premium members only.

The historical data trend for Cell Point (India)'s EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cell Point (India) EBIT Chart

Cell Point (India) Annual Data
Trend Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
EBIT
Get a 7-Day Free Trial 88.55 168.48 79.27 79.91 74.13

Cell Point (India) Semi-Annual Data
Mar20 Mar21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 21.13 28.12 51.79 32.25 41.88

NSE:CELLPOINT vs CASY, WSM, ULTA: EBIT Comparison

For the Specialty Retail subindustry, Cell Point (India)'s EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cell Point (India) EV-to-EBIT vs Retail - Cyclical Industry

For the Retail - Cyclical industry and Consumer Cyclical sector, Cell Point (India)'s EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Cell Point (India)'s EV-to-EBIT falls into.


NSE:CELLPOINT
73GF Score
Cell Point (India) Ltd NSE:CELLPOINT
EBIT is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Cell Point (India) EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the semi-annually data reported by the company within the most recent 12 months, which was ₹74 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT →
What does a EBIT of ₹74 Mil mean?
Cell Point (India) (NSE:CELLPOINT) has a EBIT of ₹74 Mil as of Mar. 2026. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Cell Point (India).
Is Cell Point (India)'s EBIT too high?
Cell Point (India)'s current EBIT is ₹74 Mil. Overall, Cell Point (India) has a GF Score™ of 73/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Cell Point (India)'s EBIT compare to CASY and WSM?
Cell Point (India)'s EBIT of ₹74 Mil can be compared against companies in the Retail - Cyclical industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Retail - Cyclical company?
A good EBIT depends on the Retail - Cyclical industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Cell Point (India). Cell Point (India)'s current EBIT is ₹74 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cell Point (India) stock overvalued right now?
Based on GuruFocus' analysis, Cell Point (India) (NSE:CELLPOINT) is currently considered Significantly Undervalued. The stock's GF Value™ is ₹34.71, compared to a current price of ₹15.85 — trading 54.3% below its estimated fair value. The current EBIT is ₹74 Mil. Cell Point (India)'s overall GF Score™ is 73/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For Cell Point (India) (NSE:CELLPOINT), the current EBIT is ₹74 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Cell Point (India) (NSE:CELLPOINT) Overvalued in 2026?

Based on GuruFocus' analysis, Cell Point (India) stock appears to be undervalued. The current stock price of ₹15.85 is trading 54.3% below its estimated GF Value™ of ₹34.71. GuruFocus considers Cell Point (India) to be Significantly Undervalued.

Key valuation signals for NSE:CELLPOINT:

  • EBIT: ₹74 Mil
  • GF Value™: ₹34.71 vs. price of ₹15.85 (54.3% below fair value)
  • GF Score™: 73/100 with 7 warning signs

No single metric tells the full story. See the NSE:CELLPOINT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Cell Point (India) Business Description

Address Lalitha Colony, Door No. 30-15-134, Dabagardens, Visakhapatnam, AP, IND, 530020
Cell Point (India) Ltd is engaged in multi-brand retail selling of smartphones, tablets, mobile accessories, and mobile-related products of various brands such as Apple, Samsung, Oppo, Realme, Nokia, Vivo, Xiaomi, Nokia, Redmi, Techno, One Plus, etc. It is also engaged in retail selling of consumer durable electronics goods, smart televisions, smart watches, and air conditioners of various brands such as Xiaomi, Realme, and One Plus among others. The company operates in a single segment and derives revenue from its operations in India.
73GF Score

Get the complete analysis for NSE:CELLPOINT

EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹15.85
Price
₹34.71
GF Value